Journal article
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
F Xavier Bosch, Thomas R Broker, David Forman, Anna-Barbara Moscicki, Maura L Gillison, John Doorbar, Peter L Stern, Margaret Stanley, Marc Arbyn, Mario Poljak, Jack Cuzick, Philip E Castle, John T Schiller, Lauri E Markowitz, William A Fisher, Karen Canfell, Lynette A Denny, Eduardo L Franco, Marc Steben, Mark A Kane Show all
Vaccine | ELSEVIER SCI LTD | Published : 2013
Grants
Awarded by European Commission
Awarded by Instituto de Salud Carlos III (Spanish Government)
Awarded by Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government)
Awarded by USPHS/NIH/National Cancer Institute (grant "Human Papillomavirus Gene Expression")
Awarded by USPHS/NIH/National Cancer Institute (grant "Mechanisms of Human Papillomavirus DNA Replication")
Awarded by US Public Health Service (National Cancer Institute, National Institutes of Health, Department of Health and Human Services)
Awarded by National Institute of AIDS and Infectious Disease
Awarded by UK Medical Research Council
Awarded by Vrije Universiteit Amsterdam, the Netherlands
Awarded by Cancer Research UK programme
Awarded by National Health and Medical Research Council, Australia
Awarded by Bill and Melinda Gates Foundation, USA
Awarded by U.S. National Cancer Institute
Awarded by Bill and Melinda Gates Foundation
Awarded by Medical Research Council
Funding Acknowledgements
The work was partially supported by public grants from the European Commission (7th Framework Programme grants HEALTH-F3-2010-242061, PREHDICT and HEALTH-F2-2011-282562, HPV AHEAD), from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI08/1535, FIS PI10/02995, FIS PI11/02090, FIS PI11/02096, FIS PI11/02104, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056 and CIBERESP) and from the Agencia de Gestio d'Ajuts Universitaris i de Recerca - Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695 and AGAUR 2009SGR126), who had no role in data collection, analysis or interpretation of results. Thomas R. Broker receives research support from the USPHS/NIH/National Cancer Institute (grants "Human Papillomavirus Gene Expression" CA36200 and "Mechanisms of Human Papillomavirus DNA Replication" CA83679). Anna-Barbara Moscicki's work is supported by US Public Health Service grant R37 CA51323 (National Cancer Institute, National Institutes of Health, Department of Health and Human Services) and National Institute of AIDS and Infectious Disease RC1 AI86051. John Doorbar is funded by the UK Medical Research Council through program grant MC_U117584278 (Molecular Biology of Human Papillomavirus Infection). Marc Arbyn received financial support from: (1) the 7th Framework Programme of DG Research of the European Commission through the PREHDICT project (grant No. 242061, coordinated by the Vrije Universiteit Amsterdam, the Netherlands) and through the HPV AHEAD Network (FP7-HEALTH-2011-282562); (2) the Belgian Foundation Against Cancer (Brussels, Belgium); and (3) the International Agency for Research on Cancer (Lyon, France). Jack Cuzick was supported in part by Cancer Research UK programme grant A10404. Karen Canfell is supported by grants from the National Health and Medical Research Council, Australia (CDF APP1007994 and Project Grant #1007518), by non-commercial government and academic consulting agreements in Australia, New Zealand and the UK, and by Cancer Council NSW, Australia. Lynette A. Denny was partially supported by Bill and Melinda Gates Foundation, USA (35537). The work of Chris J.L.M. Meijer received support via the 7th Framework Programme of DG Research of the European commission through the PREHDICT project (grant 242061, coordinated via the Vrije Universiteit Amsterdam). Jane J. Kim is supported in part by grants from the U.S. National Cancer Institute (U54 CA164336, R01 CA160744-01A1) and the Bill and Melinda Gates Foundation (30505) for modeling of HPV and cervical cancer in developing countries.